This presentation aims to educate pharmacists at Duke Regional and Duke Raleigh Hospitals on hepatorenal syndrome (HRS), starting with a broad disease overview of terminology, epidemiology, pathophysiology, and clinical presentation. This will be followed by an explanation of the medications used in HRS and how the various American and European guidelines recommend their use. The remainder of the presentation will focus on terlipressin, including an assessment of pertinent primary medical literature and a discussion of the pharmacists’ role in terlipressin management. Assessment questions will be dispersed throughout to engage the audience in self-assessment of the presented material. The presentation will occur twice between January 9-11, 2024.